Expertise at the service of patients
A recognized specialist in the engagement of patients, users, relatives and citizens in the transformation of health systems, the integration of care and clinical governance, Marie-Pascale Pomey has cutting-edge expertise in participatory intervention research, in the evaluation of health policies and organizations and in partnership with the people concerned. His work, carried out in Canada and abroad, has contributed to the development of innovative models promoting continuity of care, patient empowerment and improvement in the quality of services, particularly in the context of chronic diseases and complex transitions between care teams.
A principal clinical fellow in evaluation of technologies and intervention modalities from the CHUM, the Fonds de recherche du Québec and the Ministry of Health and Social Services since March 2017, she is also a reference in the engagement of citizens and patients in intervention research. Its research program is structured around three complementary axes: analysis of the role of new health technologies in the evolution of relationships between professionals and patients and in the organization of care; the co-construction of interventions with patients and their loved ones at all levels of the health system, from public policies to clinical care, in order to better meet their needs; and the design of measurement tools to analyze, support and sustain this commitment.
Towards an integrated model of post-treatment care
Over the next three years, Marie-Pascale Pomey and her team will analyze, co-construct and test an integrated model of post-treatment care for women aged 65 and over undergoing adjuvant endocrine treatment after breast cancer.
The PRIME-OncoTBC project adopts a participatory intervention research approach, combining quantitative and qualitative methods and giving ample space to patients at all stages of the project. This model aims to empower patients while strengthening coordination between oncology services and primary care in order to respond to the challenges related to persistent side effects, fragmentation of care and adherence to long-term treatment.
The expected results will make it possible to formulate concrete and transferable recommendations to guide health policies and support the implementation of integrated models of care following breast cancer treatment that promote equity, quality of life and partnership with patients.
